Today, Johnson & Johnson, Merk and Bristol Myers Squibb are testifying in front of the Senate Health, Education, Labor, and Pensions (HELP) Committee. Listening to what the drugmaker executives have to say about medicine prices would ordinarily be a valuable exercise. But under the proverbial interrogation lamp of HELP Committee Chairman Bernie Sanders (I-Vt.), the proceedings will be more akin to the Salem witch trials.
The committee hearing is set to focus on price disc...